Search Results - "Govaerts, A."
-
1
Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach
Published in Annals of oncology (01-12-2018)“…The molecular landscape of squamous cell carcinoma of the head and the neck (SCCHN) has been characterized and actionable or targetable genomic alterations…”
Get full text
Journal Article -
2
Use of hare bone for the manufacture of a Clovis bead
Published in Scientific reports (05-02-2024)“…A tubular bone bead dating to ~ 12,940 BP was recovered from a hearth-centered activity area at the La Prele Mammoth site in Converse County, Wyoming, USA…”
Get full text
Journal Article -
3
Historical legacies and ecological determinants of grass naturalizations worldwide
Published in Ecography (Copenhagen) (01-09-2020)“…The global distribution of exotic species is the result of abiotic, biotic and dispersal filtering processes that shape the movement and success of species…”
Get full text
Journal Article -
4
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
Published in European journal of cancer (1990) (01-01-2009)“…Abstract The combination of oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX-4) is still a reference regimen in advanced colorectal cancer; however, the…”
Get full text
Journal Article -
5
Nomenclatural changes in Coleus and Plectranthus (Lamiaceae): a tale of more than two genera
Published in PhytoKeys (23-08-2019)“…A synopsis of the genera Coleus Lour, Equilabium A.J.Paton, Mwany. & Culham and Plectranthus L’Hér. (Lamiaceae, Tribe Ocimeae, Subtribe Plecranthinae) is…”
Get full text
Journal Article -
6
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
Published in Cancer chemotherapy and pharmacology (01-04-2008)“…Purpose OSI-7904L is a liposomal formulation of a potent thymidylate synthase (TS) inhibitor. This phase I study evaluated the safety, tolerability and…”
Get full text
Journal Article -
7
The 2030 Declaration on Scientific Plant and Fungal Collecting
Published in Plants, people, planet (30-09-2024)“…Societal Impact Statement Biological samples and their associated information are an essential resource used by scientists, governments, policymakers,…”
Get full text
Journal Article -
8
-
9
524P Cell line study of nucleosome-based biomarkers in the diagnosis and detection of relapses in glioblastoma
Published in Annals of oncology (01-10-2023)Get full text
Journal Article -
10
rWCVP: a companion R package for the World Checklist of Vascular Plants
Published in The New phytologist (01-11-2023)“…The World Checklist of Vascular Plants (WCVP) is an extremely valuable resource that is being used to address many fundamental and applied questions in plant…”
Get full text
Journal Article -
11
-
12
706TiP Phase III study assessing the “best of” radiotherapy compared to the “best of” surgery (trans-oral surgery (TOS)) in patients with T1-T2, N0-N1 oropharyngeal, supraglottic carcinoma and with T1, N0 hypopharyngeal carcinoma
Published in Annals of oncology (01-09-2022)Get full text
Journal Article -
13
-
14
Retrovirus-mediated gene transfer of the human multidrug resistance-associated protein into hematopoietic cells protects mice from chemotherapy-induced leukopenia
Published in Human gene therapy (20-03-1999)“…Utilization of chemotherapy for the treatment of tumors is mainly limited by its hematological toxicity. Because of the low-level expression of drug resistance…”
Get more information
Journal Article -
15
-
16
1109O - A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
Published in Annals of oncology (01-10-2019)“…Patients (pts) with RM SCCHN progressing after platinum have a median overall survival (OS) of 7-8 months with nivolumab or pembrolizumab. No other drug has…”
Get full text
Journal Article -
17
1109OA phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
Published in Annals of oncology (01-10-2019)“…Abstract Background Patients (pts) with RM SCCHN progressing after platinum have a median overall survival (OS) of 7-8 months with nivolumab or pembrolizumab…”
Get full text
Journal Article -
18
Jules Bordet (1870-1961)
Published in Revue médicale de Bruxelles (01-06-1999)Get more information
Journal Article -
19
Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness
Published in Cancer gene therapy (01-09-1999)“…The transfer of genes encoding cytokines into tumor cells has emerged as a new strategy to increase in vivo host reactivity to a variety of tumors. Because…”
Get full text
Journal Article -
20
Suggestive Evidence for Receptors for Morphine and Methionine-Enkephalin on Normal Human Blood T Lymphocytes
Published in The Journal of immunology (1950) (01-09-1979)“…This study reports the in vitro influence of morphine, dextromoramide, levomoramide, and methionine-enkephalin upon normal human T blood lymphocytes by using…”
Get full text
Journal Article